The recent disruptions in global chains have highlighted the value of securing critical medications like Ivermectin. Relying on overseas manufacturers exposes regions to considerable vulnerabilities, including shipping delays, cost fluctuations, and even political concerns. Moving towards domestic procurement of Ivermectin offers a multitude of ups